Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

Arthritis & Rheumatology(2025)10.1002/art.43391Source: DataRank Database

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus is a research paper published in Arthritis & Rheumatology (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 3.58)OA: hybridTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Duanping Liao ORCID,Judith A. James ORCID,Joel M. Guthridge ORCID,Cristina Arriens ORCID,Diane L. Kamen ORCID

Live enrichment

PubMed:40955637 PMC:PMC13054461 OpenAlex:https://openalex.org/W4414248287

National Institutes of Health

Grant: P30AR073750

National Institutes of Health

Grant: U01AI76244

National Institutes of Health

Grant: U01AR071077

National Institutes of Health

Grant: U54GM104938

National Institutes of Health

Grant: U54TR002014

National Institutes of Health

Grant: UL1TR001881

National Institutes of Health

Grant: UL1TR003163

National Institutes of Health

Grant: UM1AI144292

FWCI

3.58

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.43391

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.43391

publisherhttps://acrjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/art.43391

publisherhttps://acrjournals.onlinelibrary.wiley.com/doi/full-xml/10.1002/art.43391

journalhttps://doi.org/10.1002/art.43391

Fields of Study

Systemic Lupus Erythematosus ResearchDrug-Induced Ocular ToxicityRheumatoid Arthritis Research and TherapiesHumansHydroxychloroquineAdultFemaleDouble-Blind MethodMaleLupus Erythematosus, SystemicAntirheumatic AgentsMiddle AgedYoung AdultAdolescentDisease ProgressionAntibodies, AntinuclearTreatment OutcomeSeverity of Illness Index

MeSH Terms

AdolescentAdultAntibodies, AntinuclearDouble-Blind MethodFemaleHumansHydroxychloroquineLupus Erythematosus, SystemicMaleMiddle AgedSeverity of Illness IndexTreatment OutcomeDisease ProgressionAntirheumatic AgentsYoung Adult

Keywords

HydroxychloroquineLupus erythematosusSystemic lupus erythematosusImmunopathologyConnective tissue diseaseAutoimmune disease

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

FAIR Checklist

Authors (15)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)